Skip to NavigationSkip to content

News

The FDA has announced its approval of a combination of Opdivo and Yervoy for the treatment of previously untreated advanced renal cell carcinoma...
Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK and Canada, but...
Amgen has lifted the curtain on complete Phase 3 data for Aimovig in the treatment of episodic migraine in patients who had previously failed two to...
After a busy start to the year, with a number of acquisitions and a few divestments, Sanofi’s Chief Financial Officer, Jérôme Contamine, is set to...
GW Pharma are inching step by step towards a likely approval with the FDA, after it received a strong recommendation within a briefing document prior...
Novartis has revealed it is to invest $100 million into the research and development of new treatments for malaria over the next five years,...
Two weeks ago, it looked like the hopes for Alkermes’ ALKS 5461 receiving approval would rely on returning to the clinic to undergo the lengthy...
Last year buzz about Amazon entering the pharmaceutical distribution market steadily grew after it obtained pharmacy licenses in a small number of US...
MSD is once again flexing Keytruda’s muscles, this time unveiling that the anti-PD-1 drug has excelled in combination with chemotherapy in the...
Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, by appointing William Chin to join the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches